Research ArticleOriginal Article
Open Access

Prevalence, hematological parameters, and coagulation profiles

Cardiovascular diseases statistics in the Asir region, Saudi Arabia

Kholoud N. Almetairi, Sultan Z. Alasmari, Mohammed H. Makkawi and Ahmad A. Shaikh
Saudi Medical Journal April 2023, 44 (4) 385-393; DOI: https://doi.org/10.15537/smj.2023.44.4.20220746

References

  1. 1.↵
    1. Sanchis-Gomar F,
    2. Perez-Quilis C,
    3. Leischik R,
    4. Lucia A.
    Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med 2016; 4: 256.
    OpenUrl
  2. 2.↵
    1. Li N,
    2. Zhou H,
    3. Tang Q.
    Red blood cell distribution width: A novel predictive indicator for cardiovascular and cerebrovascular diseases. Dis Markers 2017; 2017: 7089493.
  3. 3.↵
    1. Townsend N,
    2. Wilson L,
    3. Bhatnagar P,
    4. Wickramasinghe K,
    5. Rayner M,
    6. Nichols M.
    Cardiovascular disease in Europe: Epidemiological update 2016. Eur Heart J 2016; 37: 3232–3245.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Alshaikh MK,
    2. Filippidis FT,
    3. Baldove JP,
    4. Majeed A,
    5. Rawaf S.
    Women in saudi arabia and the prevalence of cardiovascular risk factors: A systematic review. J Environ Public Health 2016; 2016: 7479357.
  5. 5.↵
    1. Almansour HA,
    2. Aloudah NF,
    3. Alhawassi TM,
    4. Chaar B,
    5. Krass I,
    6. Saini B.
    Cardiovascular disease risk prevention services by pharmacists in saudi arabia: What do policymakers and opinion leaders think? J Pharm Policy Pract 2021; 14: 1–16.
    OpenUrl
  6. 6.↵
    1. Hazazi A,
    2. Wilson A.
    Noncommunicable diseases and health system responses in saudi arabia: Focus on policies and strategies. A qualitative study. Health Res Policy Syst 2022; 20: 63.
    OpenUrl
  7. 7.↵
    1. Saquib N,
    2. Zaghloul MS
    , AbdulRahman Mazrou and Juliann Saquib. Cardiovascular disease research in saudi arabia: A bibliometric analysis. Scientometrics 2017; 112: 111–140.
    OpenUrl
  8. 8.↵
    1. Haybar H,
    2. Pezeshki SMS,
    3. Saki N.
    Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? Exp Mol Pathol 2019; 110: 104267.
    OpenUrlCrossRef
  9. 9.↵
    1. de Moura Monteiro Júnior JG,
    2. de Oliveira Cipriano Torres D,
    3. Filho DCS.
    Hematological parameters as prognostic biomarkers in patients with cardiovascular diseases. Curr Cardiol Rev 2019; 15: 274–282.
    OpenUrl
  10. 10.↵
    1. Krishna V,
    2. Pillai G,
    3. Sukumaran SV.
    Red cell distribution width as a predictor of mortality in patients with sepsis. Curēus 2021; 13: e12912.
    OpenUrl
  11. 11.↵
    1. Mo M,
    2. Huang Z,
    3. Huo D,
    4. Pan L,
    5. Xia N,
    6. Liao Y, et al.
    Influence of red blood cell distribution width on all-cause death in critical diabetic patients with acute kidney injury. Diabetes Metab Syndr Obes 2022; 15: 2301–2309.
    OpenUrl
  12. 12.↵
    1. Nkambule BB,
    2. Mxinwa V,
    3. Nyambuya TM,
    4. Dludla PV.
    The mean platelet volume and atherosclerotic cardiovascular-risk factors in adults with obesity: A systematic review and meta-analysis of observational studies. BMC Nutr 2022; 8: 4.
    OpenUrl
  13. 13.↵
    1. Cakir L,
    2. Aktas G,
    3. Enginyurt O,
    4. Cakir SA.
    Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Medica Mediterranea 2014; 30: 425–428.
    OpenUrl
  14. 14.
    1. Kocak MZ,
    2. Aktas G,
    3. Erkus E,
    4. Duman TT,
    5. Atak BM,
    6. Haluk Savli
    . Mean platelet volume to lymphocyte ratio as a novel marker for diabetic nephropathy. J Coll Physicians Surg Pak 2018; 28: 844–847.
    OpenUrlPubMed
  15. 15.
    1. Bilgin S,
    2. Tel BMA,
    3. Kahveci G,
    4. Duman TT,
    5. Kurtkulagi O,
    6. Yurum S, et al.
    Hypothyroidism is strongly correlated with mean platelet volume and red cell distribution width. J Health Sci 2021; 6: 7–10.
    OpenUrl
  16. 16.
    1. Dagistan Y,
    2. Dagistan E,
    3. Gezici AR,
    4. Halicioglu S,
    5. Akar S,
    6. Özkan N, et al.
    Could red cell distribution width and mean platelet volume be a predictor for lumbar disc hernias? Ideggyogy Sz 2016; 69: 411–414.
    OpenUrl
  17. 17.
    1. Aktaş G,
    2. Çakıroğlu B,
    3. Şit M,
    4. Üyetürk U,
    5. Alçelik A,
    6. Savlı H, et al.
    Mean platelet volume : A simple indicator of chronic prostatitis. Acta Medica Mediterranea 2013; 29: 551–554.
    OpenUrl
  18. 18.
    1. Aktas G,
    2. Alcelik A,
    3. Tekce BK,
    4. Tekelioglu V,
    5. Sit M,
    6. Savli H.
    Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Prz Gastroenterol 2014; 9: 160–163.
    OpenUrl
  19. 19.
    1. Çakır L,
    2. Aktaş G,
    3. Mercimek OB,
    4. Enginyurt O,
    5. Kaya Y.
    Are red cell distribution width and mean platelet volume associated with rheumatoid arthritis? BIomed Res J 2016; 27.
  20. 20.
    1. Aktas G,
    2. Mehmet Zahid Kocak, Tuba Taslamacioglu Duman,
    3. Edip Erkus, Burcin Meryem Atak,
    4. Mustafa Sit, et al.
    Mean platelet volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Medical Journal 2018; 7.
  21. 21.
    1. Karagoz I,
    2. Aktas G,
    3. Yoldas H,
    4. Yildiz I,
    5. Ogun MN,
    6. Bilgi M, et al.
    Association between hemogram parameters and survival of critically ill patients. J Intensive Care 2019; 34: 511–513.
    OpenUrl
  22. 22.↵
    1. Kosekli MA.
    Mean platelet volume and platelet to lymphocyte count ratio are associated with hepatitis B-related liver fibrosis. Eur J Gastroenterol Hepatol 2022; 34: 324–327.
    OpenUrl
  23. 23.↵
    1. Adam AM,
    2. Ali MA,
    3. Shah AA,
    4. Rizvi AH,
    5. Rehan A,
    6. Godil A, et al.
    Efficacy of hematological and coagulation parameters in the diagnosis and prognosis of patients with acute coronary syndrome. J Tehran Heart Cent 2018; 13: 115.
    OpenUrl
  24. 24.↵
    1. Babes EE,
    2. Zaha DC,
    3. Tit DM,
    4. Nechifor AC,
    5. Bungau S,
    6. Andronie-Cioara FL, et al.
    Value of hematological and coagulation parameters as prognostic factors in acute coronary syndromes. Diagnostics 2021; 11: 850.
    OpenUrl
  25. 25.↵
    1. Roth GA,
    2. Johnson C,
    3. Abajobir A,
    4. Abd-Allah F,
    5. Abera SF,
    6. Abyu G, et al.
    Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017; 70: 1–25.
    OpenUrlFREE Full Text
  26. 26.↵
    1. Alem MM,
    2. Alshehri AM,
    3. Alshehri MA,
    4. AlElaiw MH,
    5. Almaa AA,
    6. Bustami RT.
    Red blood cell distribution width (RDW) in chronic heart failure: Does it have a prognostic value in every population? Electron J Gen Med 2022; 19: em338.
    OpenUrl
  27. 27.↵
    1. Khan MA,
    2. Hashim MJ,
    3. Mustafa H,
    4. Baniyas MY,
    5. Al Suwaidi, Shaikha Khalid Buti Mohamad,
    6. Rana AlKatheeri, et al.
    Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus 2020; 12: e9349.
    OpenUrl
  28. 28.↵
    1. Gao Z,
    2. Chen Z,
    3. Sun A,
    4. Deng X.
    Gender differences in cardiovascular disease. Medicine In Novel Technology And Devices 2019; 4: 100025.
    OpenUrl
  29. 29.↵
    1. Kelly BB,
    2. Valentin Fuster
    . Promoting cardiovascular health in the developing world: A critical challenge to achieve global health. Washington (DC): National Academies Press (US); 2010.
  30. 30.↵
    1. Jan AF,
    2. Habib S,
    3. Naseeb K,
    4. Khatri MA,
    5. Zaman KS.
    High total leukocyte count and heart failure after myocardial infarction. Pak Heart J 2011; 44: 8–17.
    OpenUrl
  31. 31.↵
    1. Pernow J,
    2. Mahdi A,
    3. Yang J,
    4. Zhou Z.
    Red blood cell dysfunction: A new player in cardiovascular disease. Cardiovasc Res 2019; 115: 1596–1605.
    OpenUrl
  32. 32.↵
    1. Madjid M,
    2. Fatemi O.
    Components of the complete blood count as risk predictors for coronary heart disease: In-depth review and update. Tex Heart Inst J2013; 40: 17.
    OpenUrlPubMed
  33. 33.↵
    1. Pan J,
    2. Borné Y,
    3. Engström G.
    The relationship between red cell distribution width and all-cause and cause-specific mortality in a general population. Scientific Reports 2019; 9: 16208.
    OpenUrl
  34. 34.↵
    1. Atak Tel B,
    2. Kahveci G,
    3. Bilgin S,
    4. Kurtkulagi O,
    5. Duman TT,
    6. Demirkol M, et al.
    Haemoglobin and red cell distribution width levels in internal medicine patients indicate recurrent hospital admission during COVID-19. Fam Med Prim Care Rev 2022; 24: 32–36.
    OpenUrl
  35. 35.↵
    1. Ranjith MP,
    2. DivyaRaj R,
    3. Mathew D,
    4. George B,
    5. Krishnan MN
    . Mean platelet volume and cardiovascular outcomes in acute myocardial infarction. Heart Asia 2016; 8: 16–20.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Pafili K,
    2. Penlioglou T,
    3. Mikhailidis DP,
    4. Papanas N.
    Mean platelet volume and coronary artery disease. Curr Opin Cardiol 2019; 34: 390–398.
    OpenUrl
  37. 37.↵
    1. Anvari MS,
    2. Tavakoli M,
    3. Lotfi-Tokaldany M,
    4. Broumand M,
    5. Rezahosseini O,
    6. Hakki-Kazzazi E, et al.
    Coronary artery disease presentation and its association with shortened activated partial thromboplastin time. J Tehran Heart Cent 2018; 13: 1–5.
    OpenUrl
  38. 38.↵
    1. Kiriş T,
    2. Vatansever S,
    3. Yazici S,
    4. Çelik A,
    5. Variş E,
    6. M Karaca, et al.
    Prognostic value of prothrombin time in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Koşuyolu Heart Journal 2018; 21: 98–107.
    OpenUrl
  39. 39.↵
    1. Saxena S,
    2. Saxena N,
    3. Jain R,
    4. Jasani J.
    Analysis of prothrombin time (PT) and activated partial thromboplastin time (aPTT) in patients with acute myocardial infarction on anticoagulation therapy to assess the thrombogenic potential. J Physiol 2021; 21: 1058–1061.
    OpenUrl
  40. 40.↵
    1. Khan HA,
    2. Alhomida AS,
    3. Al Rammah TY,
    4. Sobki SH,
    5. Ola MS,
    6. Khan AA.
    Alterations in prothrombin time and activated partial thromboplastin time in patients with acute myocardial infarction. Int J Clin Exp Med 2013; 6: 294.
    OpenUrlPubMed
  41. 41.↵
    1. Grover SP,
    2. Mackman N.
    Tissue factor in atherosclerosis and atherothrombosis. Atherosclerosis 2020; 307: 80–86.
    OpenUrl
  42. 42.↵
    1. Wong CC,
    2. Ng A,
    3. Lau KJ,
    4. Vincent Chow, Vivien Chen,
    5. Arnold CT Ng, et al.
    High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy. Thromb Haemost 2016; 115: 1191–1199.
    OpenUrl
  43. 43.↵
    1. Steenbergen C,
    2. Frangogiannis NG. Ischemic Heart Disease
    . In Muscle: Fundamental Biology and Mechanisms of Disease. Elsevier; 2012. pp. 495–521
  44. 44.↵
    1. Berry C.
    Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease. Circulation 2017; 136: 437–439.
    OpenUrlFREE Full Text
  45. 45.
    1. Jensen RV,
    2. Hjortbak MV,
    3. Bøtker HE.
    Ischemic heart disease: An update. Semin Nucl Med 2020; 50: 195–207.
    OpenUrl
  46. 46.↵
    1. Shahjehan RD,
    2. Bhutta BS.
    Coronary artery disease. StatPearls 2021.
  47. 47.↵
    1. Maulood KA.
    Assessment of some hematological, biochemical parameters and cardiac biomarker levels in patients with ischemic heart disease in erbil city. Zanco J Med Sci 2018; 30: 86–93.
    OpenUrl
  48. 48.↵
    1. Song M,
    2. Graubard BI,
    3. Rabkin CS,
    4. Engels EA.
    Neutrophil-to-lymphocyte ratio and mortality in the united states general population. Sci Rep 2021; 11: 464.
    OpenUrlCrossRef
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords